165 related articles for article (PubMed ID: 1299008)
1. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
[TBL] [Abstract][Full Text] [Related]
2. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients.
Piscitelli J; Cabansag MR; Silverstein DM
J Pediatr Endocrinol Metab; 1999; 12(6):879-86. PubMed ID: 10614547
[TBL] [Abstract][Full Text] [Related]
3. Renal osteodystrophy with hyperparathyroidism: the diagnostic value of intact parathormone, alkaline phosphatase, osteocalcin and procollagen.
Rubini G; Anelli F; Correale M; Lauriero F; Rubini D; D'Addabbo A
J Nucl Biol Med (1991); 1994 Sep; 38(3):489-94. PubMed ID: 7865545
[TBL] [Abstract][Full Text] [Related]
4. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
5. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
[No Abstract] [Full Text] [Related]
6. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
8. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E
J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
[No Abstract] [Full Text] [Related]
9. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
[No Abstract] [Full Text] [Related]
10. Renal osteodystrophy in hemodialysis patients.
Oda H; Yorioka N; Takemasa A; Shigemoto K; Harada S; Ito T; Masaki T; Yamakido M
Hiroshima J Med Sci; 1995 Sep; 44(3):83-8. PubMed ID: 8567317
[TBL] [Abstract][Full Text] [Related]
11. [Bone mineral content in premenopausal women treated with gonadotropin-releasing hormone analogue].
Masahashi T; Negoro Y; Asai M; Suzuki M; Noguchi M; Nakanishi M; Tomita A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):577-80. PubMed ID: 1619317
[TBL] [Abstract][Full Text] [Related]
12. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
Heaf JG; Nielsen LP; Mogensen NB
Nephron; 1983; 35(2):103-7. PubMed ID: 6621754
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
15. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
Joffe P; Heaf JG; Jensen C
Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers.
Montalbán C; García-Unzueta MT; De Francisco AL; Amado JA
Horm Metab Res; 1999 Jan; 31(1):14-7. PubMed ID: 10077343
[TBL] [Abstract][Full Text] [Related]
17. Osteodystrophy in Indonesian haemodialysis patients.
Santoso D; Yogiantoro M; Tomino Y
Nephrology (Carlton); 2003 Oct; 8(5):261-5. PubMed ID: 15012715
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
Kohara N
Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
[TBL] [Abstract][Full Text] [Related]
20. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]